Hepatitis C Treatment Study in Myanmar
Condition: Hepatitis C Intervention: Drug: Sofosbuvir 400 mg Sponsor: Myanmar Oxford Clinical Research Unit Not yet recruiting - verified May 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials